Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03500757 · ClinicalTrials.gov registry record

Intra-procedural 360-degree Display for Performing Percutaneous Liver Tumor Ablation

A clinical trial, sponsored by Case Comprehensive Cancer Center.

Completed
Registry status
11
Enrollment target

NCT03500757 is a clinical trial that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 11 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03500757 has completed, sponsored by Case Comprehensive Cancer Center.

COMPLETED
Registry status
11 participants
Enrollment target

Study Summary

Medical images used to guide treatment of tumor(s) are presently displayed on flat-panel monitors (like screens used with computers). This protocol will evaluate, using a new headset to view the images in true 3D ("360 degrees"), while using standard flat panel monitors as usual (in accordance with standard of care). The headset is combined with a mini-global positioning system (GPS)-like system to help navigate to treat tumor(s). This evaluation is to show that the headset has potential to provide guidance and navigation information that can improve the treatment of tumor(s) with heat.

Interventions

  • DEVICE HoloLens

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2018-04-29
Est. Completion 2022-05-16

Sponsor

Case Comprehensive Cancer Center

407 total trials

What the Registry Record Tells You About NCT03500757

The ClinicalTrials.gov registry entry for NCT03500757 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which HoloLens is the first listed.

NCT03500757 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03500757 about?

NCT03500757 is a clinical study titled "Intra-procedural 360-degree Display for Performing Percutaneous Liver Tumor Ablation". Medical images used to guide treatment of tumor(s) are presently displayed on flat-panel monitors (like screens used with computers). This protocol will evaluate, using a new headset to view the images in true 3D ("360 degrees"), while using standard flat panel monitors as usual (in accordance with ...

What is the current status of trial NCT03500757?

This trial is currently completed. The enrollment target is 11 participants. The study started on 2018-04-29. Estimated completion is 2022-05-16.

What interventions are being tested in trial NCT03500757?

The interventions under investigation include: HoloLens (DEVICE).

Who is sponsoring clinical trial NCT03500757?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.